What is BJDX's current stock price?

BJDX (Bluejay Diagnostics, Inc.) is currently trading at $1.92 with a market cap of $870.8K.

What sector is Bluejay Diagnostics, Inc. in?

Bluejay Diagnostics, Inc. (BJDX) operates in the Healthcare sector, specifically in the Medical - Devices industry.

InvestLog

BJDX Bluejay Diagnostics, Inc.

Healthcare

$1.92-1.54%ClosedMarket Cap: $870,799

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

0.21

P/S

0.00

EV/EBITDA

0.40

DCF Value

$10.79

FCF Yield

-763.7%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

-144.3%

ROA

-123.3%

ROIC

-163.5%

Financials

View All

Period	Revenue	Net Income	EPS
Q1 null	$0.00	$-1.9M	$—
Q4 null	$0.00	$-1.4M	$—
FY null	$0.00	$-6.8M	$—
Q3 null	$0.00	$-1.6M	$—

Analyst Ratings

View All

Consensus

Hold

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

0 Strong Buy0 Buy1 Hold0 Sell0 Strong Sell

Trading Activity

Insider Trades

View All

ZEIDMAN FRED Sdirector

BuyMon May 18

Wurth Douglas Clarkdirector

BuyMon May 18

Dey Svetlanadirector

BuyMon May 18

Dey Indranildirector, officer: President and CEO

BuyMon May 18

CHASE DONALD Rdirector

BuyMon May 18

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

Exchange

—

Beta

0.72

Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers the Symphony platform, a technology platform comprising the Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and the Symphony Cartridge, which includes reagents and components. It also provides the ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, the company develops Symphony IL-6 tests for the monitoring of disease progression in critical care settings. Further, it is developing additional tests for Symphony, such as tests for myocardial infraction and congestive heart failure. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.

Peers

UPC

WGS